Farmaceutica REMEDIA S.A. (BVB: RMAH)
Romania
· Delayed Price · Currency is RON 0.746
+0.002 (0.27%)
At close: Sep 27, 2024
Farmaceutica REMEDIA Income Statement
Financials in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 664.14 | 593.36 | 535.85 | 477.1 | 441.48 | 446.41 | Upgrade
|
| Revenue | 664.14 | 593.36 | 535.85 | 477.1 | 441.48 | 446.41 | Upgrade
|
| Revenue Growth (YoY) | 18.80% | 10.73% | 12.31% | 8.07% | -1.11% | -3.80% | Upgrade
|
| Cost of Revenue | 629.95 | 558.54 | 500.19 | 447.83 | 403.69 | 403.84 | Upgrade
|
| Gross Profit | 34.19 | 34.82 | 35.66 | 29.27 | 37.79 | 42.57 | Upgrade
|
| Selling, General & Admin | 22.29 | 20.62 | 22.13 | 19.47 | 27.58 | 34.79 | Upgrade
|
| Other Operating Expenses | 1.7 | 2.38 | 3.08 | 0.32 | 6.19 | 7.59 | Upgrade
|
| Operating Expenses | 28.68 | 28.06 | 29.23 | 21 | 34.87 | 43.63 | Upgrade
|
| Operating Income | 5.51 | 6.76 | 6.43 | 8.28 | 2.92 | -1.06 | Upgrade
|
| Interest Expense | -0.16 | -0.12 | -0.16 | -0.11 | -0.17 | -0.64 | Upgrade
|
| Interest & Investment Income | 1.15 | 0.94 | 0.47 | 0.16 | 0.09 | 0.22 | Upgrade
|
| Earnings From Equity Investments | -0.35 | -0.28 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.09 | -0.04 | -0.08 | -0.06 | -0.02 | -0.04 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.45 | 0.35 | 0.13 | -0.14 | 0.06 | -0.04 | Upgrade
|
| EBT Excluding Unusual Items | 6.5 | 7.6 | 6.79 | 8.13 | 2.87 | -1.56 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.31 | 1.31 | 0.27 | 0.51 | 39.9 | 4.68 | Upgrade
|
| Pretax Income | 7.81 | 8.91 | 7.06 | 8.63 | 42.77 | 3.12 | Upgrade
|
| Income Tax Expense | 4.31 | 1.71 | 1.25 | 1.4 | 5 | 0.68 | Upgrade
|
| Net Income | 3.49 | 7.2 | 5.81 | 7.23 | 37.77 | 2.44 | Upgrade
|
| Net Income to Common | 3.49 | 7.2 | 5.81 | 7.23 | 37.77 | 2.44 | Upgrade
|
| Net Income Growth | -40.06% | 23.97% | -19.69% | -80.85% | 1447.31% | -19.51% | Upgrade
|
| Shares Outstanding (Basic) | 103 | 96 | 96 | 95 | 106 | 106 | Upgrade
|
| Shares Outstanding (Diluted) | 103 | 96 | 96 | 95 | 106 | 106 | Upgrade
|
| Shares Change (YoY) | 7.37% | -0.03% | 0.13% | -10.06% | -0.03% | 0.09% | Upgrade
|
| EPS (Basic) | 0.03 | 0.08 | 0.06 | 0.08 | 0.36 | 0.02 | Upgrade
|
| EPS (Diluted) | 0.03 | 0.08 | 0.06 | 0.08 | 0.36 | 0.02 | Upgrade
|
| EPS Growth | -44.17% | 24.01% | -19.79% | -78.71% | 1447.83% | -19.58% | Upgrade
|
| Free Cash Flow | 17.74 | 21.84 | -2.03 | 2.59 | -13.6 | 4.05 | Upgrade
|
| Free Cash Flow Per Share | 0.17 | 0.23 | -0.02 | 0.03 | -0.13 | 0.04 | Upgrade
|
| Dividend Per Share | 0.050 | 0.050 | 0.050 | 0.050 | 0.150 | - | Upgrade
|
| Dividend Growth | 0% | 0% | 0% | -66.67% | - | - | Upgrade
|
| Gross Margin | 5.15% | 5.87% | 6.65% | 6.14% | 8.56% | 9.54% | Upgrade
|
| Operating Margin | 0.83% | 1.14% | 1.20% | 1.73% | 0.66% | -0.24% | Upgrade
|
| Profit Margin | 0.53% | 1.21% | 1.08% | 1.52% | 8.56% | 0.55% | Upgrade
|
| Free Cash Flow Margin | 2.67% | 3.68% | -0.38% | 0.54% | -3.08% | 0.91% | Upgrade
|
| EBITDA | 10.05 | 11.67 | 10.45 | 9.14 | 3.44 | -0.41 | Upgrade
|
| EBITDA Margin | 1.51% | 1.97% | 1.95% | 1.92% | 0.78% | -0.09% | Upgrade
|
| D&A For EBITDA | 4.54 | 4.91 | 4.02 | 0.86 | 0.52 | 0.65 | Upgrade
|
| EBIT | 5.51 | 6.76 | 6.43 | 8.28 | 2.92 | -1.06 | Upgrade
|
| EBIT Margin | 0.83% | 1.14% | 1.20% | 1.73% | 0.66% | -0.24% | Upgrade
|
| Effective Tax Rate | 55.25% | 19.16% | 17.69% | 16.22% | 11.68% | 21.83% | Upgrade
|
| Revenue as Reported | 667.57 | 598.28 | 539.2 | 477.95 | 482.8 | 452.13 | Upgrade
|
| Advertising Expenses | - | 0.12 | 0.05 | 0.04 | 0.08 | 0.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.